Intensity Therapeutics INTS
NASDAQ INTS
$3.23 +0.02 (+0.62%)
As of: Oct 2, 2026 · 10:49 AM EDT

Intensity Therapeutics (INTS) Cash from Investing Activities (2023 - 2024)

Updated

Intensity Therapeutics' Cash from Investing Activities was $6.35 million in FY2024, compared with -$6.02 million in FY2023.

Analysis

Intensity Therapeutics (INTS) Cash from Investing Activities (2023 - 2024) Analysis & Trends

  • Per Business Quant data, Cash from Investing Activities in earlier years was -$6.02 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.11 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -1.20 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -5.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.11 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.91 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -569.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.35 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.11 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -45.80 Mn
10 Intensity Therapeutics 9.93 Mn 9.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 3.10 Mn
Jun 30, 2024 -6,000.00
Mar 31, 2024 3.26 Mn
Dec 31, 2023 2.82 Mn
Sep 30, 2023 -8.84 Mn
API Access

Intensity Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=INTS&period=max&api_key=YOUR_API_KEY